Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration.
Anthony GigonAntonio IskandarSophie KasserSacha NasoMarta ZolaIrmela MantelPublished in: Eye (London, England) (2024)
Incomplete responders to anti-VEGF showed a significant short-term response, identifiable at 1 week after injection, with rapid recurrence at 1 month. Weaker short-term responsiveness at 1 week was associated with poorer long term visual prognosis. These patients may need adjuvant treatment to improve their prognosis.
Keyphrases
- age related macular degeneration
- end stage renal disease
- vascular endothelial growth factor
- endothelial cells
- ejection fraction
- newly diagnosed
- chronic kidney disease
- early stage
- prognostic factors
- peritoneal dialysis
- clinical trial
- patient reported outcomes
- randomized controlled trial
- ultrasound guided
- combination therapy
- study protocol
- replacement therapy
- loop mediated isothermal amplification
- double blind